Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease.

David SimonKoray TascilarFilippo FagniKatja SchmidtGerhard KrönkeArnd Kleyer Andreas Ramming Verena SchönauDaniela BohrJohannes KnitzaThomas HarrerKarin MangerBernhard Manger Larissa Valor-Méndez

Published in: Annals of the rheumatic diseases (2021)

Overall, these data strongly argue in favor of a third vaccination in patients with IMID lacking response to standard vaccination irrespective of their B cell status.

Keyphrases

sars cov
electronic health record
respiratory syndrome coronavirus
oxidative stress
coronavirus disease
machine learning
deep learning
data analysis